Saudi Arabia Antibiotics Market to grow with a CAGR of 4.78%
Increasing
healthcare infrastructure and a supportive regulatory environment are the major
drivers for the Saudi Arabia Antibiotics Market.
According
to TechSci Research report, “Saudi Arabia Antibiotics Market Industry Size,
Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Saudi Arabia Antibiotics
Market has valued at USD 0.90 billion in 2022 and is anticipated to witness an
impressive growth in the forecast period with a CAGR of 4.78% through
2028. This can be due to collaborations
and partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market.
Rising awareness about healthcare and the
importance of responsible antibiotic use can indeed drive the demand for
antibiotics. As people become more health-conscious and informed, they may be
more likely to seek medical attention when they suspect an infection that
requires antibiotic treatment. This increased patient demand can drive
prescription rates. A population that is more aware of the potential risks of
untreated infections and the benefit of antibiotic treatment is more likely to
visit healthcare providers when necessary. This can result in a higher demand
for antibiotics. Government and healthcare organizations often run public
health campaigns to educate the public about various health issues, including
the responsible use of antibiotics. These campaigns can influence public
behavior and increase awareness about the importance of appropriate antibiotic
use.
Healthcare
providers, including doctors and pharmacists, are often at the forefront of
educating patients about antibiotics. Increased awareness among healthcare
professionals can lead to more responsible antibiotic prescribing and
dispensing. Many countries participate in global antibiotic awareness campaigns
and initiatives like World Antibiotic Awareness Week. These events draw
attention to the issue of antibiotic resistance and encourage responsible
antibiotic use.
Browse
over XX market data Figures and spread through XX Pages and an in-depth TOC on
“Saudi Arabia Antibiotics Market.”
In March 2022, Cumberland Pharmaceuticals Inc.,
headquartered in Nashville, and Tabuk Pharmaceutical Manufacturing Company, a
fully owned subsidiary of Astra Industrial Group and a leading pharmaceutical
company in the Middle East, headquartered in Riyadh, Saudi Arabia, have jointly
announced the introduction of Cumberland's Vibativ (telavancin) injection in
the Middle East. This announcement follows a collaboration between the two
companies, granting Tabuk exclusive rights to register and promote the product
for patients in Saudi Arabia, Jordan, and potentially other Middle Eastern
countries. Vibativ represents a potentially life-saving treatment for patients
with hospital-acquired and ventilator-associated pneumonia caused by various
Gram-positive bacterial pathogens, including those that are difficult to treat
and multidrug-resistant.
Generic
competition is a challenge in the Saudi Arabia antibiotics market, as it is in
pharmaceutical markets worldwide. When the patents for brand-name antibiotics
expire, generic pharmaceutical companies can produce and market equivalent
versions, often at a lower cost. This can lead to increased competition for the
same antibiotics. Generic antibiotics are typically more cost-effective than
their brand-name counterparts, which can put pressure on the prices of
antibiotics in the market. This can be beneficial for patients and healthcare
systems but may reduce the profitability of antibiotic manufacturers. As more
generic versions of antibiotics become available, the market may become
saturated with multiple competing products. This can lead to price wars and
further price reductions. Healthcare
providers may increasingly prescribe generic antibiotics to reduce healthcare
costs, which can influence patient and pharmacy choices. Patients and
healthcare providers may become less loyal to specific brand-name antibiotics
when effective and more affordable generic alternatives are available.
Saudi Arabia Antibiotics Market is segmented based
on Drug Class,
Spectrum, Source, Route of Administration, Distribution Channel, and by region.
Based on the Spectrum, Saudi Arabia Antibiotics
Market is segmented into Broad Spectrum Antibiotics, Narrow Spectrum
Antibiotics. Broad-spectrum antibiotics are a category of antibiotics that are
effective against a wide range of different types of bacteria. These
antibiotics are capable of targeting and killing a diverse group of bacteria,
including both Gram-positive and Gram-negative bacteria. Broad-spectrum
antibiotics are versatile and can be used to treat a wide variety of bacterial
infections when the specific type of bacteria causing the infection is unknown
or when multiple types of bacteria are involved. They are effective against
both Gram-positive and Gram-negative bacteria. This includes common bacteria
responsible for a range of infections, such as Staphylococcus, Streptococcus,
Escherichia coli, and Pseudomonas aeruginosa. Broad-spectrum antibiotics are
often used in clinical practice when there is uncertainty about the precise
bacterial cause of an infection or in severe infections where a rapid response
is essential and waiting for detailed diagnostic information may be
impractical. Some examples of broad-spectrum antibiotics include certain
penicillins, cephalosporins, fluoroquinolones, and carbapenems. These
antibiotics have a broad spectrum of activity and can target a wide range of
bacteria.
Based on Region, Northern & Central region held the largest share in the Saudi Arabia
Antibiotics Market. The Saudi government often directs healthcare
investments towards these regions due to their importance in terms of
population and economic activity. This can lead to more healthcare facilities
and resources available for antibiotic distribution. Major pharmaceutical
companies and distributors are likely to be concentrated in these regions,
ensuring a steady supply of antibiotics. There may be a greater level of health
awareness and education in these regions, which can influence
healthcare-seeking behavior and responsible antibiotic use.
Some
of the major companies operating in the Saudi
Arabia Antibiotics Market include:
- Novartis
AG Saudi Arabia
- Pfizer
Saudi Limited
- Glenmark
Pharmaceuticals Saudi Arabia
- GlaxoSmithKline
Saudi Arabia Limited
- AstraZeneca
Saudi Arabia
Download Free Sample Report
Customers can also request 10% free
customization on this report.
“Certain areas, particularly in North
America, are projected to exert significant demand for Antibiotics. The growth
in the competitive landscape and the presence of well-established companies in
the market, committed to enhance the overall wellbeing of people each year, are
expected to contribute to a remarkable growth of the Saudi Arabia Antibiotics
Market in the forecast period," said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based Global management consulting firm.
Saudi Arabia
Antibiotics Market by Drug Class (Cephalosporin, Penicillin, Amoxicillin,
Azithromycin, Clindamycin, Tetracycline, Others), By Spectrum (Broad Spectrum
Antibiotics, Narrow Spectrum Antibiotics), By Source (Natural, Semisynthetic,
Synthetic), By Route of Administration (Oral, Intravenous), By Distribution
Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By
Region, By Competition Forecast
& Opportunities, 2018-2028F has
evaluated the future growth potential of Saudi Arabia Antibiotics Market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide innovative market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Saudi Arabia Antibiotics Market.
Contact Us-
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
M: +13322586602
Email: [email protected]
Website: www.techsciresearch.com